4CPS-065 Safety of bevacizumab biosimilar in clinical practice in new and switched treatmets

Autor:	M Cardenas Sierra, M Palacios Filardo, FJ Goikolea Ugarte, AM de Juan Arroyo, O Ibarra Barrueta, A Knecht, G Mirón Elorriaga, A Martín Torrente, M Cobas Belso, L Menéndez Liendo, P Gemio Zumalave
Rok vydání:	2022
Zdroj:	Section 4: Clinical pharmacy services.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c27404a052e383ab3c9ac79d933ef91c https://doi.org/10.1136/ejhpharm-2022-eahp.104 Zobrazit plný text záznamu